Clinical and Molecular Characterization af autosomal recessive chronic granulomatous disease caused by p47-phox deficiency;Caracterización clínico - Molecular de la enfermedad granulomatosa crónica autosómica recesiva causada por déficit de p47-phox

Revista Medica de Chile

Volumn 128, Issue 5, 2000, Pages 490-498

  Cornejo De L, Mónica ^a   López Q, Juan A ^b   Navarro V, Sara ^b   García De O, Diana ^b   Patiño G , Pablo J ^b  

^a UNIVERSIDAD DE VALPARAÍSO   (Chile)

^b NONE

Author keywords

DNA mutational analysis; Granulomatous disease, chronic; NADPH oxidase; Respiratory burst

Indexed keywords

EID: 0346985957     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. LEUSEN J, VERHOEVEN A, Roos D. Interactions between the components of the human NADPH oxidase: intrigues in the phox family. J Lab Clin Med 1996; 128: 461-76.
2. CLARK R. Activation of the neutrophil respiratory burst oxidase. J Infect Dis 1999; 179 (Suppl 2): S309-17.
3. ROOS D, DE BOER M, KURIBAYASHI F, MEISCHL C, WEENING R, SEGAL A, ET AL. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease, Blood 1996; 87: 1663-81.
4. MALY F, NAKAMURA M, GAUCHAT J, URWYLER A, WALKER C, DAHINDEN C, ET AL. Superoxide -dependent NBT reduction and expression of cytochrome b-245 components by human tonsillar B lymphocytes and B cell lines. J Immunol 1989; 142: 1260-7.
5. BOYUM A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest 1968; 21 (suppl 97): 77-89.
6. CURNUTTE J, SCOTT P, BABIOR B. Functional defect in neutrophil cytosol from two patients with autosomal recessive cytochrome-positive chronic granulomatous disease. J Clin Invest 1989; 83: 1236-40.
7. GIRALDO M, GARCÍA D. Producción del anión superóxido en polimorfonucleares neutrófilos. Microtécnica para su medición. Acta Med Colomb 1989; 14: 82-6.
8. NEWBURGER P, SKALNIK D, HOPKINS P, EKLUND E, CURNUTTE J. Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558. J Clin Invest 1994; 94: 1205-11.
9. ROLFS A, SCHULLER Y, FINCKH U, WEBER-ROLFS I (EDS). PCR: principles and reaction components. In PCR: Clinical Diagnostics and research. Berlin: Spring Verlag 1992, 1-21.
10. VOLPP B, NAUSEEF W, DONELSON J, MOSER D, CLARK R. Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. Proc Natl Acad Sci (USA) 1986; 86: 9563-8.
11. BROWN M. Sequencing with Taq DNA polymerase. In Innis M, Gelfand D, Sninsky J, White T (eds). PCR protocols. A guide to methods and applications. San Diego CA: Academic Press Inc 1990, 189-94.
12. AUSUBEL F, BRENT R, KINGSTON R, MOORE D, SEIDMAN J, SMITH J, ET AL. Current protocols in immunology. New York, NY: John Wiley & Sons Inc 1991; A.3A.1-3.
13. WEENING R, ADRIAANSZ L, WEEMAES C, LUTTER R, ROOS D. Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b-positive neutrophils. J Pediatr 1985; 107: 102-4
14. SHAPIRO B, NEWBURGER P, KLEMPNER M, DINAUER M. Chronic granulomatous disease presenting in a 69-year-old man. N Engl J Med 1991; 325: 1786-90.
15. VOWELLS S, FLEISHER T, SEKHSARIA S, ALLING D, MAGUIRE T, MALECH H. Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr 1996; 128: 104-7.
16. IWATA M, NUNOI H, YAMAZAKI H, NAKANO T, NIWA H, TSURUTA S, ET AL. Homologous dinucleotide (GT or TG) deletion in Japanese patients with chronic granulomatous disease with p47-phox deficiency. Biochem Biophys Res Commun 1994; 199: 1373-77.
17. CASIMIR C, BU-GHANIM H, RODAWAY A, BENTLEY D, ROWE P, SEGAL A. Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat. Proc Natl Acad Sci (USA) 1991; 88: 2753-57.
18. GORLACH A, LEE P, ROESLER J, HOPKINS P, CHRISTENSEN B, GREEN E, ET AL. A 47-phox pseudogene carries the most common mutation causing p47-phox deficient chronic granulomatous disease. J Clin Invest 1997; 100: 1907-18.
19. MALECH H. Progress in gene therapy for chronic granulomatous disease. J Infect Dis 1999; 179 (Suppl 2): S318-25.
20. ZELAZKO M, CARNEIRO-SAMPAIO M, CORNEJO M, GARCÍA D, PORRAS O, BERRON R, ET AL. Primary immunodeficiency diseases in Latin America: First report from eight countries participating in the LAGID. J Clin Immunol 1998; 18: 161-6.